	2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	417	550	700	860	1,107	1,201	1,423	1,826	2,012	2,184	2,604	3,193	3,489	3,642	3,739
Cost of Operating Revenue	167	205	257	320	439	467	548	733	781	854	1,119	1,289	1,419	1,437	1,438
Gross Profit	250	345	443	540	669	734	875	1,093	1,231	1,330	1,485	1,904	2,070	2,205	2,301
Gross Margin	59.9	62.7	63.3	62.7	60.4	61.2	61.5	59.9	61.2	60.9	57.0	59.6	59.3	60.5	61.5
Total Operating Expenses	334	441	506	644	806	931	1,155	1,451	1,628	1,804	2,173	2,576	2,842	3,028	3,209
Operating Profit	82	109	194	216	301	270	269	375	384	380	432	617	647	614	529
Operating Margin	19.8	19.7	27.7	25.1	27.2	22.5	18.9	20.5	19.1	17.4	16.6	19.3	18.5	16.9	14.2
Financing Income/(Expense) - Net	-10	-7	-39	-14	-20	70	107	41	61	54	84	-16	-13	12	-40
Profit before Taxes	74	106	156	204	281	347	373	415	517	469	484	594	621	660	411
Income Taxes	3	4	22	29	40	59	67	84	105	64	89	129	111	164	94
Profit after Tax	71	102	134	175	241	287	305	332	412	405	396	464	510	496	317
PAT Margin	17.0	18.6	19.1	20.4	21.8	23.9	21.5	18.2	20.5	18.5	15.2	14.5	14.6	13.6	8.5
EPS - Basic - ex Extraordinary Items	1.77	2.55	3.35	4.60	6.19	7.35	7.71	8.38	10.38	10.18	9.94	11.59	12.71	12.35	7.87
EPS - Diluted - ex Extraordinary Items	1.77	2.55	3.35	4.45	6.10	7.28	7.68	8.36	10.35	10.11	9.82	11.51	12.69	12.33	7.87
EBIT	82	109	194	216	301	270	269	375	384	380	432	617	647	614	529
EBITDA	137	169	259	297	398	385	400	535	600	651	737	977	1,066	1,040	976
EBITDA Margin	32.9	30.6	37.1	34.6	36.0	32.0	28.1	29.3	29.8	29.8	28.3	30.6	30.5	28.5	26.1

Balance Sheet

Abridged

Understanding Balance Sheet

Syngene International Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	R 2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	PR	AR	AR	AR	IR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	138	237	634	554	1,335	1,524	1,720	1,764	1,613	1,807	2,206	2,425	1,959	2,287	2,143
Long-Term Investments	0	0	-	-	-	3	-	40	74	316	309	267	76	72	592
Property Plant & Equipment - Net	394	390	439	603	811	969	1,168	1,596	2,197	2,382	2,688	2,777	3,618	4,003	3,970
Total Non-Current Assets	449	487	557	815	1,021	1,251	1,469	1,939	2,550	3,077	3,358	3,406	4,193	4,509	4,912
Total Assets	587	724	1,191	1,368	2,356	2,775	3,189	3,704	4,163	4,883	5,564	5,831	6,152	6,796	7,055
Total Current Liabilities	220	149	462	475	534	600	784	1,129	1,539	1,133	1,229	1,188	1,144	1,396	1,552
Long Term Debt	4	-	-	19	725	690	586	362	81	618	742	703	465	409	399
Total Non-Current Liabilities	70	57	69	97	797	761	685	607	448	929	1,037	1,025	750	673	663
Total Liabilities	290	206	532	573	1,331	1,362	1,469	1,735	1,987	2,062	2,266	2,213	1,894	2,069	2,216
Total Shareholders' Equity	297	519	659	796	1,025	1,413	1,720	1,968	2,176	2,821	3,298	3,618	4,258	4,727	4,839
Total Equity	297	519	659	796	1,025	1,413	1,720	1,968	2,176	2,821	3,298	3,618	4,258	4,727	4,839
Total Liabilities & Equity	587	724	1,191	1,368	2,356	2,775	3,189	3,704	4,163	4,883	5,564	5,831	6,152	6,796	7,055

Cash Flow

Abridged

Understanding Cash Flow Statement

Syngene International Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	108	135	179	237	338	399	469	474	688	699	769	861	914	1,052	897
Working Capital - Increase/(Decrease)	6	-36	129	-216	-26	37	-27	182	44	37	-180	-18	181	152	58
Net CF from Operating Activities	114	99	308	21	313	436	442	656	732	736	589	843	1,095	1,204	955
Capital Expenditures - Net	26	59	97	204	294	306	364	583	643	447	476	518	489	770	368
Net CF from Investing Activities	-24	-152	-383	2	-757	-524	-368	-702	-518	-690	-638	-710	-577	-795	-911
Dividends Paid - Cash - Total	-	-	-	114	20	-	24	24	24	-	-	40	50	50	50
Stock - Issuance/(Retirement) - Net	5	120	-	133	2	2	5	2	1	1	-	-	-	1	0
Debt - LT & ST - Issuance/(Retirement) - Total	-65	-93	156	-3	739	-66	-37	-20	-166	85	-14	-268	-472	-78	-154
Net Cash Flow from Financing Activities	-60	27	156	-2	717	-64	-56	-43	-191	86	-14	-308	-523	-128	-204
Free Cash Flow to Equity	22	-53	367	-186	758	64	42	52	-78	374	100	57	134	356	433
Free Operating CF net dividend	87	38	209	-297	-2	129	54	48	64	289	114	285	534	384	537
Free Operating CF	87	38	209	-183	18	129	79	73	89	289	114	325	584	434	587

Business Segment Analysis

FY End:

Mar 26

Syngene International Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Contract Research and Manufacturing Services. (100.0%)₹ 368.20 Cr

Revenue / Sales

Contract Research and Manufacturing Services. (100.0%)₹ 3,738.70 Cr

Assets

Contract Research and Manufacturing Services. (100.0%)₹ 7,054.70 Cr

Operating Income

Contract Research and Manufacturing Services. (100.0%)₹ 529.30 Cr

Regional Segment Analysis

FY End:

Mar 26

Syngene International Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

United States of America (62.8%)₹ 2,348.40 CrEurope (30.7%)₹ 1,146.20 CrRest of the World (3.9%)₹ 146.00 CrIndia (2.6%)₹ 98.10 Cr

Historical Segment Analysis

Track how Syngene International Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Contract Research and Manufacturing Services.	447	476	518	511	770	368

Frequently Asked Questions

What is the revenue of Syngene International Ltd.?

The latest trailing twelve month revenue of Syngene International Ltd. is ₹ 3,738.70 Cr, reflecting a 1-year growth of 2.64% and a 3-year CAGR of 5.40%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Syngene International Ltd.?

The latest trailing twelve month net profit (PAT) of Syngene International Ltd. is ₹ 316.70 Cr, with a 3-year earnings CAGR of -11.89%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Syngene International Ltd.?

The trailing twelve month EBITDA of Syngene International Ltd. is approximately ₹ 526.50 Cr (based on an operating margin of 14.08%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Syngene International Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Syngene International Ltd. is 7.87. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Syngene International Ltd.?

The debt-to-equity ratio of Syngene International Ltd. stands at 0.09. The interest coverage ratio is 10.79x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Syngene International Ltd.?

The estimated book value per share of Syngene International Ltd. is 122.54 (derived from a P/B ratio of 3.42 and market price of ₹ 419.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Syngene International Ltd.?

The trailing twelve month operating cash flow of Syngene International Ltd. is ₹ 955.40 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Syngene International Ltd. report consolidated or standalone financials?

Syngene International Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.